Corey Seager undergoes elbow surgery to remove bone spur

Corey Seager has undergone surgery to remove a bone spur from his elbow, MLB.com reported, a development that raises significant availability concerns for the Texas Rangers shortstop heading into the offseason.

What happened

Brian Murphy of MLB.com reported that Seager had the bone spur removed from his elbow. The procedure follows a stretch of days in which the situation had been building publicly: the Rangers announced earlier in the week that Seager was a candidate for offseason elbow surgery, a designation that carried its own layer of uncertainty at the time. Now the surgery itself is no longer a question of if.

The Rangers also announced around the same period that infielder Josh Jung was a candidate for offseason surgery of his own, meaning the club enters the winter with multiple significant roster health questions to sort through before spring.

Why it matters

Seager is the centerpiece of the Rangers' lineup — the kind of player whose presence or absence reshapes what a roster can reasonably ask of itself. An elbow procedure, even one framed as bone spur removal rather than something more structurally alarming, introduces real uncertainty about where he stands heading into next season. The club has not announced a timetable, and none has been reported.

That uncertainty is the operative word here. The surgery has happened. What comes next — recovery length, spring availability, whether there are any downstream concerns — remains unconfirmed as of this report. A bone spur removal is not automatically a long-road procedure, but the absence of a stated timeline means the Rangers and their fans are in a familiar offseason posture: waiting.

Is Seager expected to be ready for next season?

No timetable has been reported. MLB.com's report establishes that the surgery occurred and that it raises significant availability concerns, but neither the club nor the reporting has attached a specific return window to the procedure. That is the central open question the Rangers front office will be managing as the offseason begins.

Where the club stands

Texas finished at 80-82 (.494), sitting 2nd in the AL West and 1 game back in the division — though the club has already been eliminated from both the division race and the Wild Card race. Their Wild Card ranking sits 4th, 4.0 games relative to the cut line, a margin that rendered the final stretch of the schedule largely academic. The team dropped its most recent game, entering this report on an L1 streak.

That 80-82 record is the backdrop against which this surgery lands. A club that finished below .494 and out of the postseason picture is now navigating an offseason that includes at least two players — Seager and Jung — with surgical procedures either completed or under consideration. The front office's work this winter is not merely about adding; it is about accounting for what it already has.

Second place in the AL West with a losing record is the kind of standing that invites a long look in the mirror. The distance between a championship and 80-82 is the story of this franchise's recent arc, and Seager's availability next spring is a meaningful variable in whether that arc bends back upward.

What we don't know yet

The recovery timetable is the obvious gap. No timeline has been reported, and the club has not announced one. Whether Seager will be fully available for spring training, limited in some capacity, or facing a longer runway into the regular season is entirely open.

It is also worth noting that the Rangers have not announced an IL placement in connection with this surgery — though as a general matter of roster mechanics, a surgical procedure of this nature would typically prompt one. That is a roster administration question the club will address in its own time; the reporting as it stands covers the surgery itself, not the downstream paperwork.

Josh Jung's situation adds another layer. The Rangers announced him as a surgery candidate around the same time Seager's situation was developing, but the specifics of Jung's procedure — if and when it occurs — have not been reported in the same detail. Two players in the infield mix with offseason health questions is a meaningful planning constraint for a front office that needs to rebuild toward contention.

What to watch

The first thing to watch is any club announcement regarding a timetable for Seager's recovery. That number — whenever it arrives — will set the table for how aggressively the Rangers need to address shortstop depth this winter, and how much of their offseason planning can proceed with Seager penciled in as a full participant versus a question mark.

The second thread is Jung. His candidacy for surgery was announced in the same breath as Seager's, and an update on whether that procedure has occurred or is still pending will matter for how the Rangers construct their infield picture heading into next year.

And the broader question — the one that hangs over all of it — is what an 80-82 season and a pair of surgical offseasons say about where this roster is relative to the AL West's upper tier. The Rangers have the talent, or have had it. Whether they can get it healthy and on the field at the same time is the operational challenge that will define their winter.

For now, the surgery is done. Everything else is still being written.